- Home
- SDHY vs TMCI Comparison
SDHY vs TMCI Comparison
Compare SDHY & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDHY
- TMCI
- Stock Information
- Founded
- SDHY 2020
- TMCI 2014
- Country
- SDHY United States
- TMCI United States
- Employees
- SDHY N/A
- TMCI N/A
- Industry
- SDHY Finance/Investors Services
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SDHY Finance
- TMCI Health Care
- Exchange
- SDHY Nasdaq
- TMCI Nasdaq
- Market Cap
- SDHY 400.4M
- TMCI 371.1M
- IPO Year
- SDHY N/A
- TMCI 2021
- Fundamental
- Price
- SDHY $16.48
- TMCI $5.53
- Analyst Decision
- SDHY
- TMCI Hold
- Analyst Count
- SDHY 0
- TMCI 6
- Target Price
- SDHY N/A
- TMCI $9.18
- AVG Volume (30 Days)
- SDHY 94.0K
- TMCI 352.4K
- Earning Date
- SDHY 01-01-0001
- TMCI 08-05-2025
- Dividend Yield
- SDHY 8.46%
- TMCI N/A
- EPS Growth
- SDHY N/A
- TMCI N/A
- EPS
- SDHY 1.07
- TMCI N/A
- Revenue
- SDHY N/A
- TMCI $210,819,000.00
- Revenue This Year
- SDHY N/A
- TMCI $10.61
- Revenue Next Year
- SDHY N/A
- TMCI $10.36
- P/E Ratio
- SDHY $14.31
- TMCI N/A
- Revenue Growth
- SDHY N/A
- TMCI 7.54
- 52 Week Low
- SDHY $13.93
- TMCI $4.54
- 52 Week High
- SDHY $15.50
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- SDHY 61.59
- TMCI 34.86
- Support Level
- SDHY $16.22
- TMCI $5.36
- Resistance Level
- SDHY $16.53
- TMCI $6.28
- Average True Range (ATR)
- SDHY 0.11
- TMCI 0.24
- MACD
- SDHY 0.01
- TMCI -0.00
- Stochastic Oscillator
- SDHY 75.55
- TMCI 16.30
About SDHY PGIM Short Duration High Yield Opportunities Fund
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return, through a combination of current income and capital appreciation. Its seeks to achieve its objective by investing in a diversified portfolio of high yield fixed income instruments.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.